Cancer biotechnology is a multidisciplinary field that leverages advancements in biology, genetics, and technology to understand, diagnose, and treat various forms of cancer. This specialized branch of biotechnology focuses on developing innovative tools, techniques, and therapies to combat the complexities of cancer at the molecular level. Researchers in cancer biotechnology explore the genetic basis of cancer, enabling the identification of specific biomarkers and genetic mutations associated with different types of malignancies. This knowledge is instrumental in the development of targeted therapies and personalized medicine, tailoring treatment approaches to individual patients. Additionally, cancer biotechnology plays a pivotal role in diagnostic technologies, such as molecular imaging and liquid biopsy, offering more precise and less invasive methods for cancer detection. The ongoing advancements in cancer biotechnology hold promise for groundbreaking discoveries and transformative breakthroughs in the relentless pursuit of effective cancer prevention, diagnosis, and treatment strategies.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Advancement in dual lateral flow immunoassay design for sensitive, rapid detection of rotavirus and adenovirus in stool samples
Ayan Ahmed Isse, Genexus Biotech Company, Somalia
Title :
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Diversity analyses of microbial communities in Armanis gold-polymetallic mine and acid mine drainage: Bioremediation
Anna Khachatryan, SPC Armbiotechnology of NAS of Armenia, Armenia